Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Donthamsetti, Prashant, Eduardo F. Gallo, David C. Buck, Edward L. Stahl, Ying Zhu, J. Robert Lane, Laura M. Bohn, Kim A. Neve, Christoph Kellendonk, and Jonathan A. Javitch. "Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation." Molecular psychiatry 25, no. 9 (2020): 2086-2100.

Voce, Alexandra, Richard Burns, David Castle, Bianca Calabria, and Rebecca McKetin. "A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use." Psychiatry Research 298 (2021): 113760.

Schwartz, Michael D., Juan J. Canales, Riccardo Zucchi, Stefano Espinoza, Ilya Sukhanov, and Raul R. Gainetdinov. "Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases." Expert opinion on therapeutic targets 22, no. 6 (2018): 513-526.

Chamali, Rifka, Suhaila Ghuloum, David V. Sheehan, Ziyad Mahfoud, Arij Yehya, Mark GA Opler, Anzalee Khan, Samer Hammoudeh, Yahya Hani, and Hassen Al-Amin. "Cross-validation of the Arabic Mini International Neuropsychiatric Interview, module K, for diagnosis of Schizophrenia and the Arabic positive and negative syndrome scale." Journal of Psychopathology and Behavioral Assessment 42, no. 1 (2020): 139-149.

Watanabe, Yoshiyuki, Hisashi Tanaka, Akio Tsukabe, Yuki Kunitomi, Mitsuo Nishizawa, Ryota Hashimoto, Hidenaga Yamamori, Michiko Fujimoto, Masaki Fukunaga, and Noriyuki Tomiyama. "Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia." PLoS One 9, no. 8 (2014): e104619.

Barrera, Alvaro, Owen Curwell-Parry, and Marie-Claire Raphael. "Hebephrenia is dead, long live hebephrenia, or why Hecker and Chaslin were on to something." BJPsych Advances 25, no. 6 (2019): 373-376.

Liu, Li, Dazhi Fan, Ning Ding, Yanting Hu, Guoqi Cai, Li Wang, Lihong Xin et al. "The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis." Neuroscience Letters 583 (2014): 43-48.

Jacomb, Isabella, Clive Stanton, Rohini Vasudevan, Hugh Powell, Maryanne O'Donnell, Rhoshel Lenroot, Jason Bruggemann et al. "C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls." Frontiers in immunology 9 (2018): 2230.

Uribe, Ezequiel, and María Torres. "Neuropsychological screening for schizophrenia: a brief tool to assess subtypes of schizophrenia." Rev eNeurobiol 9, no. 21 (2018): 240918.

Madularu, Dan, Waqqas M. Shams, and Wayne G. Brake. "Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats." European Journal of Neuroscience 39, no. 2 (2014): 257-265.

Keinänen, Jaakko, Outi Mantere, Tuula Kieseppä, Teemu Mäntylä, Minna Torniainen, Maija Lindgren, Jouko Sundvall, and Jaana Suvisaari. "Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis–a one year follow-up study." Schizophrenia research 169, no. 1-3 (2015): 458-463.

Uribe, Ezequiel. "Neuropsychological subtypes of schizophrenia and prefrontal circuits." ENeurobiología 7, no. 15 (2016): 4.

Yamaguchi, Takashi, Akihiro Goto, Ichiro Nakahara, Satoshi Yawata, Takatoshi Hikida, Michiyuki Matsuda, Kazuo Funabiki, and Shigetada Nakanishi. "Role of PKA signaling in D2 receptor-expressing neurons in the core of the nucleus accumbens in aversive learning." Proceedings of the National Academy of Sciences 112, no. 36 (2015): 11383-11388.

Kastrin, Andrej, Thomas C. Rindflesch, and Dimitar Hristovski. "Link prediction on a network of co-occurring mesh terms: towards literature-based discovery." Methods of information in medicine 55, no. 04 (2016): 340-346.

Briley, Paul M., Elizabeth B. Liddle, Molly Simmonite, Marije Jansen, Thomas P. White, Vijender Balain, Lena Palaniyappan, Richard Bowtell, Karen J. Mullinger, and Peter F. Liddle. "Regional brain correlates of beta bursts in health and psychosis: a concurrent electroencephalography and functional magnetic resonance imaging study." Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2020).

Huang, Eric, Malgorzata Maciukiewicz, Clement C. Zai, Arun K. Tiwari, Jiang Li, Steven G. Potkin, Jeffrey A. Lieberman, Herbert Y. Meltzer, Daniel J. Müller, and James L. Kennedy. "Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response." Pharmacogenomics 17, no. 2 (2016): 103-109.

Fond, G., O. Godin, L. Brunel, B. Aouizerate, F. Berna, E. Bulzacka, D. Capdevielle et al. "Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set." Journal of affective disorders 191 (2016): 209-215.

Yeh, En-Chi, Ming-Chyi Huang, Chang-Jer Tsai, Chun-Tse Chen, Kuan-Yu Chen, and Chih-Chiang Chiu. "Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release." Psychiatry research 230, no. 1 (2015): 13-18.

Gilbert, Alice Victoria. "Embedding the clinician-researcher pharmacist in healthcare." (2017).

Ortiz, Bruno Bertolucci, Fernanda Dal Medico Eden, Aline Silva Rodrigues de Souza, Carla Agostinho Teciano, Daniela Malatesta de Lima, Cristiano Noto, Cinthia Hiroko Higuchi, Hugo Cogo-Moreira, Rodrigo Affonseca Bressan, and Ary Gadelha. "New evidence in support of staging approaches in schizophrenia: differences in clinical profiles between first episode, early stage, and late stage." Comprehensive psychiatry 73 (2017): 93-96.